Correlation Between Seres Therapeutics and Adagene
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Adagene, you can compare the effects of market volatilities on Seres Therapeutics and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Adagene.
Diversification Opportunities for Seres Therapeutics and Adagene
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Seres and Adagene is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Adagene go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Adagene
Given the investment horizon of 90 days Seres Therapeutics is expected to under-perform the Adagene. In addition to that, Seres Therapeutics is 1.19 times more volatile than Adagene. It trades about -0.02 of its total potential returns per unit of risk. Adagene is currently generating about 0.06 per unit of volatility. If you would invest 125.00 in Adagene on September 1, 2024 and sell it today you would earn a total of 109.00 from holding Adagene or generate 87.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Seres Therapeutics vs. Adagene
Performance |
Timeline |
Seres Therapeutics |
Adagene |
Seres Therapeutics and Adagene Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seres Therapeutics and Adagene
The main advantage of trading using opposite Seres Therapeutics and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Adagene vs. Aerovate Therapeutics | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. Rezolute | Adagene vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
CEOs Directory Screen CEOs from public companies around the world |